Investing.com - Oxford BioMedica reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Oxford BioMedica announced earnings per share of £-0.27 on revenue of £64.03M. Analysts polled by Investing.com EPS of £-11.90 on revenue of £56.80M.
Oxford BioMedica 's are down 64.27% and is trading at £439.50 , still down 73.81% from its 52 week high of £1,678.00 set on Friday, September 24, 2021.
Oxford BioMedica follows other major Healthcare sector earnings this month
Oxford BioMedica's report follows an earnings missed by Spire Healthcare on Thursday, September 8, 2022, who reported EPS of £-0 on revenue of £596.2M, EPS of £2.80 on revenue of £590.80M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar